Precigen (PGEN) Deferred Taxes (2015 - 2024)
Precigen (PGEN) posted quarterly Deferred Taxes of -$89000.0 for Q4 2024, up 74.79% year-over-year from -$50919.0 in Q1 2024, and down 841.67% quarter-over-quarter from $12000.0 in Q3 2024.
Precigen (PGEN) Deferred Taxes (2015 - 2024) Analysis & Trends
Precigen (PGEN) has reported Deferred Taxes for 10 consecutive years, with -$89000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Deferred Taxes rose 74.79% year-over-year to -$89000.0; the TTM figure through Sep 2025 stood at -$89000.0 (up 95.68% YoY), while the FY2024 annual figure was -$1.8 million, down 274.74% from the prior year.
- Deferred Taxes retreated to -$89000.0 in Q4 2024 per PGEN's latest filing, from $12000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $48000.0 in Q4 2020 and bottomed at -$1.7 million in Q2 2024.
- Historically, Deferred Taxes has averaged -$144578.9 across 5 years, with a median of -$56000.0 in 2021.
- Annual changes were most pronounced in 2023 — Deferred Taxes slumped 3041.67% — and 2024, when it surged 192.31%.
- Precigen's Deferred Taxes stood at $48000.0 in 2020, then tumbled by 72.92% to $13000.0 in 2021, then slipped by 7.69% to $12000.0 in 2022, then plunged by 3041.67% to -$353000.0 in 2023, then soared by 74.79% to -$89000.0 in 2024.
- Business Quant data shows PGEN's Deferred Taxes at -$89000.0 in Q4 2024, $12000.0 in Q3 2024, and -$1.7 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -89,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | -1.69 Mn |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | -353,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -58,000.00 |
| Mar 31, 2023 | -55,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Sep 30, 2022 | -50,000.00 |
| Jun 30, 2022 | -54,000.00 |
| Mar 31, 2022 | -58,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | -61,000.00 |
| Jun 30, 2021 | -63,000.00 |
| Mar 31, 2021 | -56,000.00 |
| Dec 31, 2020 | 48,000.00 |
| Sep 30, 2020 | -68,000.00 |
| Jun 30, 2020 | -136,000.00 |
| Dec 31, 2019 | -2.23 Mn |